Sansure Biotech (SHSE:688289) Net Income (Continuing Operations) : ¥213 Mil (TTM As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Sansure Biotech Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Sansure Biotech's Net Income (Continuing Operations) for the three months ended in Sep. 2024 was ¥27 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥213 Mil.

Sansure Biotech Net Income (Continuing Operations) Historical Data

The historical data trend for Sansure Biotech's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sansure Biotech Net Income (Continuing Operations) Chart

Sansure Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income (Continuing Operations)

Get a 7-Day Free Trial

39.48

2,616.60

2,242.52

1,936.71

348.17

Sansure Biotech Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															207.56	49.68	73.41	62.24	27.43

Sansure Biotech Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥213 Mil.

Sansure Biotech (SHSE:688289) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Sansure Biotech Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Sansure Biotech's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Sansure Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sansure Biotech Inc (SHSE:688289) » Definitions » Net Income (Continuing Operations)

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 680, Lusong Road, Changsha High-tech Industrial Development Zone, Hunan Province, Changsha, CHN, 410205

Website

http://www.sansure.com.cn

Sansure Biotech Inc is engaged in production and sales of diagnostic reagents and instruments. The company produces Class I medical devices, Class II medical devices, Class III medical devices, general instruments and meters, medical raw materials, medical laboratory equipment and appliances, and medical accessories.

Executives

Tan De Yong	Core technical personnel
Wang Hai Xiao	senior management
Jie Ya Ping	Core technical personnel
Zhang Ke Ya	Core technical personnel
Yang Li	Core technical personnel
Liu Rang Jiao	Core technical personnel
Deng Zhong Ping	Senior management, core technical personnel
Zhou Jun	senior management
Zhu Jian	senior management
Wu Kang	Core technical personnel
Xiong Xiao Yan	senior management
Ji Bo Zhi	Core technical personnel
Mou Wei Min	Core technical personnel
Ren Xiao Mei	Core technical personnel
Liu Kai	senior management

Sansure Biotech Headlines

No Headlines